about
Poor sensitization of 50-kHz vocalization response to amphetamine predicts rat susceptibility to self-administration of the drug.Inter-individual diversity and intra-individual stability of amphetamine-induced sensitization of frequency-modulated 50-kHz vocalization in Sprague-Dawley ratsThe effects of group III mGluR ligands on pentylenetetrazol-induced kindling of seizures and hippocampal amino acids concentration.Low-anxiety rats are more sensitive to amphetamine in comparison to high-anxiety rats.N-acetyl cysteine does not modify the sensitization of the rewarding effect of amphetamine as assessed with frequency-modulated 50-kHz vocalization in the rat.κ-opioid receptor as a key mediator in the regulation of appetitive 50-kHz ultrasonic vocalizations.The effects of acute and chronic administration of corticosterone on rat behavior in two models of fear responses, plasma corticosterone concentration, and c-Fos expression in the brain structures.Fluoxetine attenuates the effects of pentylenetetrazol on rat freezing behavior and c-Fos expression in the dorsomedial periaqueductal gray.Midazolam inhibits neophobia-induced Fos expression in the rat hippocampus.Effects of morphine and methadone treatment on mRNA expression of Gα(i) subunits in rat brains.The effects of midazolam and D-cycloserine on the release of glutamate and GABA in the basolateral amygdala of low and high anxiety rats during extinction trial of a conditioned fear test.Mapping of c-Fos expression in the rat brain during the evolution of pentylenetetrazol-kindled seizures.The role of the dorsomedial part of the prefrontal cortex serotonergic innervation in rat responses to the aversively conditioned context: behavioral, biochemical and immunocytochemical studies.The activity of beta-hexosaminidase (uHex) and gamma-glutamyltransferase (uGGT) in urine as non-invasive markers of chronic alcohol abuse: II. Opiate-dependent subjects receiving methadone substitution.Stress-opioid interactions: a comparison of morphine and methadone.Hippocampal mGluR1 and consolidation of contextual fear conditioning.Morphine and methadone pre-exposures differently modify brain regional Fos protein expression and locomotor activity responses to morphine challenge in the rat.The effect of fluoxetine in a model of chemically induced seizures--behavioral and immunocytochemical study.Methadone is substantially less effective than morphine in modifying locomotor and brain Fos responses to subsequent methadone challenge in rats.Time course of changes in the concentration of kynurenic acid in the brain of pentylenetetrazol-kindled rats.Extended blockade of the discriminative stimulus effects of nicotine with low doses of ethanol.Changes in the concentration of amino acids in the hippocampus of pentylenetetrazole-kindled rats.Buspirone attenuates conditioned fear-induced c-Fos expression in the rat hippocampus.Expression of c-Fos and CRF in the brains of rats differing in the strength of a fear response.High-anxiety rats are less sensitive to the rewarding affects of amphetamine on 50kHz USV.Effects of amphetamine administration on neurogenesis in adult rats.Colocalisation of c-Fos and glucocorticoid receptor as well as of 5-HT(1A) and glucocorticoid receptor immunoreactivity-expressing cells in the brain structures of low and high anxiety rats.Chronic ethanol tolerance as a result of free-choice drinking in alcohol-preferring rats of the WHP line.The expression of c-Fos and colocalisation of c-Fos and glucocorticoid receptors in brain structures of low and high anxiety rats subjected to extinction trials and re-learning of a conditioned fear response.Behavioral, immunocytochemical and biochemical studies in rats differing in their sensitivity to pain.Rats showing low and high sensitization of frequency-modulated 50-kHz vocalization response to amphetamine differ in amphetamine-induced brain Fos expression.The effects of morphine and morphine conditioned context on 50 kHz ultrasonic vocalisation in rats.Diverging frequency-modulated 50-kHz vocalization, locomotor activity and conditioned place preference effects in rats given repeated amphetamine treatment.Combining markers of nephrotoxicity and hepatotoxicity for improved monitoring and detection of chronic alcohol abuse.Nicotine-induced conditioned taste aversion in the rat: effects of ethanol.Sensitivity to pain and c-Fos expression in brain structures in ratsDiverse behavioral, monoaminergic and Fos protein responses to opioids in Warsaw high-alcohol preferring and Warsaw low-alcohol preferring rats
P50
Q27324591-EAF9A61E-BAC0-44B5-95E0-73B83A1607C1Q30465499-4990CC43-74C7-4B4D-8B05-567744268EC3Q34983905-C78F3435-8C3B-491D-B07C-BBE01FDE8AC3Q39323098-BCDDBBAA-B8F8-4740-B554-3D7D3A9BBB04Q41702938-8143A7C4-FEBA-4A3E-A3DF-6EF00F131228Q41735843-35F6953E-8730-4422-8DCA-11EA1A2329A9Q42603589-88E0044B-215D-4133-BB14-C1BA231A1F14Q42608268-C9BDEA68-52AF-498D-935C-72B9780D1BA1Q42676399-91FE018F-F02C-4291-A926-C60A05053516Q42754352-678B416D-FD1C-4F19-A2D4-B484ABBD00FDQ42921123-29331F45-1167-4014-8B3C-4CFA67EEE646Q43284630-D6628884-E62D-46F5-B21E-F917E780C892Q44083281-6CB39AD5-B576-48AE-8314-2C47E5B439AEQ44246813-C519B891-4A55-469E-9993-65F59AA9A558Q44343438-B61F9620-16BB-4BE4-B297-2F9EB8D405E1Q44641447-89DF315F-B8C7-4781-AABD-B7F955139C52Q44715345-D4902E20-73EA-48AE-9233-04624EAAC601Q45201860-AD644E27-529C-4B89-BB96-58B391EB75AAQ45990059-9728A769-2AA9-4EF3-8C13-D792F7C86963Q46233106-55B655E8-149F-4F94-B037-CEC9EE8C76D5Q46445619-70EBBD43-291B-4758-8B0B-5B6DC5737929Q46555786-3F64CF66-0B59-4996-B5C7-5FB74DB49F4DQ46646373-BB9E9BDD-1B79-48FE-9E1E-9BCEC5A35D14Q46859431-AA839FCA-6CD9-4331-BC5F-32232A4B92ECQ47813119-000C5641-358F-44EF-A007-8D2CCCECE706Q47842956-28962963-2A95-4B4F-B012-25F4A9876CD3Q47992340-F5BBA53D-4CC2-4488-8A95-3B82C10F458BQ48245150-9D558DAA-B471-4D56-8A9A-9C8295405F01Q48524683-8F3A3CD4-62BF-4A18-999E-F18528114EE1Q48535822-9F400292-2139-4D17-B493-28DAD0DDC7E8Q48579620-148B1724-433D-4A2F-A05A-41CB4CA73AD7Q48664367-F969200C-318B-4B7D-B8CC-0D348118B461Q50425532-397ECA57-65E3-4AAE-82D6-E1E14FC285FDQ51926855-E0383D8F-9DF7-46D8-9FD7-DA6C41B35CA0Q52020184-0896A1BA-7CB0-4BD2-891C-1F56C520F24FQ59622732-C6536E36-D38B-44BC-90B6-770913E21A5AQ83153583-8697B058-C427-449C-B88F-570A73183CF7
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8059-4966
@en
name
Ewa Taracha
@ast
Ewa Taracha
@en
Ewa Taracha
@es
Ewa Taracha
@nl
Ewa Taracha
@pl
type
label
Ewa Taracha
@ast
Ewa Taracha
@en
Ewa Taracha
@es
Ewa Taracha
@nl
Ewa Taracha
@pl
prefLabel
Ewa Taracha
@ast
Ewa Taracha
@en
Ewa Taracha
@es
Ewa Taracha
@nl
Ewa Taracha
@pl
P214
P106
P1153
7003917312
P1559
Ewa Taracha
@pl
P21
P214
P31
P3124
P496
0000-0002-8059-4966
P735
P7859
viaf-311801978